Tikva Allocell Pte Ltd
Ivan Horak is the Founder and CEO of Tikva Allocell Pte Ltd, a position held since July 2023. Prior to this role, Ivan served as President at Tessa Therapeutics from January 2019 to June 2023.
This person is not in any teams
This person is not in any offices
Tikva Allocell Pte Ltd
Tikva Allocell is a cell therapy company focused on a Second Generation Allogeneic EBV-Specific T cell (ALLO EBVST) platform to target difficult-to-treat cancers. At Tikva Allocell, our mission is to develop safe, effective, readily available and affordable “off-the-shelf” T cell therapies by leveraging excellent safety profile of ALLO EBVST and proprietary technologies that enhance the T cell's performance to treat cancer.